Efficacy of recombinant human follicle-stimulating hormone in improving oocyte quality in assisted reproductive techniques

Journal of Reproductive Medicine for the Obstetrician and Gynecologist

Volumn 49, Issue 9, 2004, Pages 733-738

  Cheon, Kang Woo ^a   Byun, Hye Kyung ^a   Yang, Kwang Moon ^a   Song, In Ok ^a   Choi, Kyu Hong ^a   Yoo, Keun Jai ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Follicle stimulating hormone; Oocytes; Reproductive techniques

Indexed keywords

GONADORELIN AGONIST; RECOMBINANT FOLLITROPIN; UROFOLLITROPIN;

ADULT; ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; CYCLIZATION; DESENSITIZATION; DOUBLE BLIND PROCEDURE; EMBRYO TRANSFER; FEMALE; FERTILITY; FERTILIZATION IN VITRO; HOSPITAL; HUMAN; HUMAN CELL; HYPOPHYSIS; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; OOCYTE; OUTPATIENT DEPARTMENT; OVARY FUNCTION; OVARY HYPERSTIMULATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; REPRODUCTION; STATISTICAL SIGNIFICANCE; TECHNIQUE;

ADULT; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; EMBRYO TRANSFER; FEMALE; FERTILITY AGENTS, FEMALE; FERTILIZATION IN VITRO; FOLLICLE STIMULATING HORMONE; FOLLICLE STIMULATING HORMONE, HUMAN; HUMANS; INFERTILITY, FEMALE; OOCYTES; OVULATION INDUCTION; PREGNANCY; PREGNANCY OUTCOME; PROSPECTIVE STUDIES; RECOMBINANT PROTEINS; TIME FACTORS; TREATMENT OUTCOME;

EID: 4544388468     PISSN: 00247758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Howles CM, Loumaye E, Giroud D, et al: Multiple follicular development and ovarian steroidogenesis following subcutaneous administration of a highly purified urinary FSH preparation in pituitary desensitized women undergoing IVF: A multicentre European phase? study. Hum Reprod 1994;9:424-430
2. Wikland M, Borg J, Hamberger L, et al: Simplification of IVF: Minimal monitoring and the use of subcutaneous highly purified FSH administration for ovarian induction. Hum Reprod 1994;9:1430-1436
3. Daya S, Gunby J, Hughes EG, et al: Follicle stimulating hormone versus human menopausal gonadotropin for in vitro fertilization cycles: Meta-analysis. Fertil Steril 1995;64:347-354
4. Bergh C, Howles CM, Borg K, et al: Recombinant human follicle stimulating hormone (r-hFSH; Gonal-F®) versus highly purified urinary FSH (Metrodin HP®): Results of randomized comparative study in women undergoing assisted reproductive techniques. Hum Reprod 1997;12:2133-2139
5. Balen AH, Hayden CJ, Rutherford AJ: Clinical efficacy of recombinant gonadotrophins. Hum Reprod 1999;14:1411-1417
6. Devroey P, Tournaye H, Steirteghem AV, et al: The use of a 100IU starting dose of recombinant follicle stimulating hormone (Puregon) in in-vitro fertilization. Hum Reprod 1998;13:565-566
7. Hoomans EH, Andersen AN, Loft A, et al: A prospective, randomized clinical trial comparing 150IU recombinant follicle stimulating hormone (Puregon®) and 225 IU highly purified urinary follicle stimulating hormone (Metrodin-HP®) in a fixed-dose regimen in women undergoing ovarian stimulation. Hum Reprod 1999;14:2442-2447
8. Yarali H, Bukulmez O, Gurgan T: Urinary follicle-stimulating hormone (FSH) versus recombinant FSH in clomiphene citrate-resistant, normogonadotropic, chronic anovulation: A prospective randomized study. Fertil Steril 1999;72:276-281
9. Frydman R, Howles CM, Truong F: A double-blind, randomized study to compare recombinant human follicle stimulating hormone (FSH; Gonal-F®) with highly purified urinary FSH (Metrodin® HP) in women undergoing assisted reproductive techniques including intracytoplasmic sperm injection. Hum Reprod 2000;15:520-525
10. Lenton E, Soltan A, Hewitt J, et al: Induction of ovulation in women undergoing assisted reproductive techniques: Recombinant human FSH (follitropin alpha) versus highly purified urinary FSH (urofollitropin HP). Hum Reprod 2000; 15:1021-1027
11. Ravhon A, Lavery S, Aurell R, et al: Clinical experience with recombinant follicle-stimulating hormone (FSH) and urinary FSH: A retrospective case-controlled analysis. Fertil Steril 2001;75:920-925
12. Daya S, Gunby J: Recombinant versus urinary follicle stimulating hormone for ovarian stimulation in assisted reproduction. Hum Reprod 1999;14:2207-2215
13. Selman HA, Santo MD, Sterzik K, et al: Effect of highly purified urinary follicle-stimulating hormone on oocyte and embryo quality. Fertil Steril 2002;73:1061-1067
14. Ng EHY, Lau EYL, Yeung WSB, et al: HMG is as good as recombinant human FSH in terms of oocyte and embryo quality: A prospective randomized trial. Hum Reprod 2001;16: 319-325
15. Veeck LL: Atlas of the Human Oocyte and Early Conceptus. Second volume. Baltimore, Williams & Wilkins, 1990
16. Phipps WR, Holden D, Sheehan RK: Use of recombinant human follicle-stimulating hormone for in vitro fertilization-embryo transfer after severe systemic immunoglobulin Emediated reaction to urofollitropin. Fertil Steril 1996;66:148-150
17. Rodgers M, McLoughlin JD, Lambert A, et al: Variability in the immunoreactive and bioactive follicle stimulating hormone content of human urinary menopausal gonadotrophin preparations. Hum Reprod 1995;10:1982-1986
18. Shaked GM, Shaked Y, Kariv-Inbal Z, et al: A protease-resistant prion protein isoform is present in urine of animals and humans affected with prion diseases. J Biol Chem 2001;276:31479-31482
19. Ulloa-Aguirre A, Espinoza R, Damian-Matsumura P, et al: Immunological and biological potencies of the different molecular species of gonadotrophins. Hum Reprod 1988;3:491-501
20. Out HJ, Mannaerts BMJL, Driessen SGAJ, et al: A prospective, randomized, assessor-blind, multicentre study comparing recombinant and urinary follicle stimulating hormone (Puregon versus Metrodin) in in-vitro fertilization. Hum Reprod 1995;10:2534-2540
21. Jacob S, Drudy L, Conroy R, et al: Outcome from consecutive in vitro fertilization/intracytoplasmic sperm injection attempts in the final group treated with urinary gonadotrophins and the first group treated with recombinant follicle stimulating hormone. Hum Reprod 1998;13:1783-1787
22. Serhal PF, Ranieri DM, Kinis A, et al: Oocyte morphology predicts outcome of intracytoplasmic sperm injection. Hum Reprod 1997;12:1267-1270
23. Ebner T, Yaman C, Moser M, et al: Prognostic value of first polar body morphology on fertilization rate and embryo quality in intracytoplasmic sperm injection. Hum Reprod 2000;15:427-430